These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7586774)

  • 1. A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis.
    Husted JA; Gladman DD; Long JA; Farewell VT
    Clin Exp Rheumatol; 1995; 13(4):439-43. PubMed ID: 7586774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
    Blackmore MG; Gladman DD; Husted J; Long JA; Farewell VT
    J Rheumatol; 1995 May; 22(5):886-93. PubMed ID: 8587077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?
    Tezel N; Yilmaz Tasdelen O; Bodur H; Gul U; Kulcu Cakmak S; Oguz ID; Karabulut E
    Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Thai version of the Health Assessment Questionnaire for patients with psoriatic arthritis.
    Katchamart W; Benjamanukul S; Chiowchanwesawakit P
    Int J Rheum Dis; 2014 Feb; 17(2):181-5. PubMed ID: 24618364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.
    Brodszky V; Péntek M; Bálint PV; Géher P; Hajdu O; Hodinka L; Horváth G; Koó E; Polgár A; Seszták M; Szántó S; Ujfalussy I; Gulácsi L
    Scand J Rheumatol; 2010 Aug; 39(4):303-9. PubMed ID: 20166848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential factors influencing health-related-quality of life in psoriasis.
    Rønneberg Mehren C; Clemmensen A; Boe-Hansen Dall A; Philipsen P; Gniadecki R
    J Drugs Dermatol; 2014 Mar; 13(3):246-50. PubMed ID: 24595566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.
    Taylor WJ; McPherson KM
    Arthritis Rheum; 2007 Jun; 57(5):723-9. PubMed ID: 17530670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis.
    Taccari E; Spadaro A; Rinaldi T; Riccieri V; Sensi F
    Rev Rhum Engl Ed; 1998 Dec; 65(12):751-8. PubMed ID: 9923043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Patient-reported Outcomes in Patients with Psoriatic Arthritis (PsA) by Body Surface Area Affected by Psoriasis: Results from the Corrona PsA/Spondyloarthritis Registry.
    Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
    J Rheumatol; 2017 Aug; 44(8):1151-1158. PubMed ID: 28620063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.
    Kwok T; Pope JE
    J Rheumatol; 2010 May; 37(5):1024-8. PubMed ID: 20231193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional impairment measurement in psoriatic arthritis: Importance and challenges.
    Mease P; Strand V; Gladman D
    Semin Arthritis Rheum; 2018 Dec; 48(3):436-448. PubMed ID: 30029795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.
    Husted JA; Gladman DD; Farewell VT; Cook RJ
    Arthritis Rheum; 2001 Apr; 45(2):151-8. PubMed ID: 11324779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in psoriatic arthritis patients in Spain.
    Gratacós J; Daudén E; Gómez-Reino J; Moreno JC; Casado MÁ; Rodríguez-Valverde V
    Reumatol Clin; 2014; 10(1):25-31. PubMed ID: 24099960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construct validity of the modified numeric rating scale of patient global assessment in psoriatic arthritis.
    Leung YY; Ho KW; Zhu TY; Tam LS; Kun EW; Li EK
    J Rheumatol; 2012 Apr; 39(4):844-8. PubMed ID: 22422489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disability assessment tools in psoriatic arthritis: VICON gait].
    Miu SS; Ancuţa C; Belibou IC; Macovei L; Chirieac R
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):50-5. PubMed ID: 23077872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secukinumab Improves Physical Function in Subjects With Plaque Psoriasis and Psoriatic Arthritis: Results from Two Randomized, Phase 3 Trials.
    Gottlieb AB; Langley RG; Philipp S; Sigurgeirsson B; Blauvelt A; Martin R; Papavassilis C; Mpofu S
    J Drugs Dermatol; 2015 Aug; 14(8):821-33. PubMed ID: 26267726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of obesity on quality of life, psychological status, and disease activity in psoriatic arthritis: a multi‑center study.
    Gok K; Nas K; Tekeoglu I; Sunar I; Keskin Y; Kilic E; Sargin B; Acer Kasman S; Alkan H; Sahin N; Cengiz G; Cuzdan N; Albayrak Gezer İ; Keskin D; Mulkoglu C; Resorlu H; Bal A; Duruoz MT; Kucukakkas O; Yurdakul OV; Alkan Melikoglu M; Aydin Y; Ayhan FF; Bodur H; Calis M; Capkin E; Devrimsel G; Ecesoy H; Hizmetli S; Kamanli A; Kutluk O; Sen N; Sendur OF; Tolu S; Toprak M; Tuncer T
    Rheumatol Int; 2022 Apr; 42(4):659-668. PubMed ID: 34453579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis.
    Chandran V; Gottlieb A; Cook RJ; Duffin KC; Garg A; Helliwell P; Kavanaugh A; Krueger GG; Langley RG; Lynde C; McHugh N; Mease P; Olivieri I; Rahman P; Rosen CF; Salvarani C; Thaci D; Toloza SM; Wong MY; Zhou QM; Gladman DD
    Arthritis Rheum; 2009 Sep; 61(9):1235-42. PubMed ID: 19714610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.
    Kavanaugh A; McInnes I; Mease P; Krueger GG; Gladman D; Gomez-Reino J; Papp K; Zrubek J; Mudivarthy S; Mack M; Visvanathan S; Beutler A
    Arthritis Rheum; 2009 Apr; 60(4):976-86. PubMed ID: 19333944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.